The British-Swedish multinational pharmaceutical and biotechnology company, AstraZeneca, has made a staggering $275 million in revenue in first quarter from…
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok